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ABSTRACT:  
Acetaldehyde (AA) is the main metabolic product in ethanol metabolism, although it can also derive from 
sources of airborne pollution. As a typical aldehyde, AA is able to react with a variety of molecular targets, 
including DNA and protein. This property justifies the hypothesis of a immune reaction against this kind of 
adduct, to be studied by a seroprevalence screening approach. In this study, the correlation between 
drinking habits and the amount of circulating AA-Human Serum Albumin adduct (AA-HSA) was evaluated in 
a group of healthy subjects, non alcohol-addicted. Daily ethanol intake (grams) was inferred for each 
subject using the information collected through a questionnaire, and AA-HSA antibodies (AA-HSA ab) 
analyses were performed using the Displacement Assay on whole blood samples. The findings showed a 
correlation between ethanol intake and immune response to molecular adduct . These results underscore 
the evaluation of AA-HSA ab amount as a suitable molecular marker for alcohol intake that can be applied 
in future investigations on a large scale for prevention screening. 
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1. INTRODUCTION 
Acetaldehyde (AA) is the first and principal product in the metabolism of ethanol. AA forms in the liver 
through detoxification reactions that are mainly catalysed by alcohol dehydrogenase and aldehyde 
dehydrogenase (Bosron and Li, 1986). However, AA also occurs in indoor environments as a member of the 
carbonyl chemical species, and it is an important factor in Indoor Air Quality evaluations (Sarigiannis et al. , 
2011). Together with formaldehyde, AA represents one of the most abundant airborne aldehydes, which 
may be related to traffic emissions, smoking, combustion appliances, cosmetic products, and some hobby 
supplies such as photographic chemicals and special adhesives (Jurvelin et al. , 2001; Wilke et al. , 2004). 
In general, aldehydes exhibit high reactivity, as they have a double bond that renders them a strong 
electrophile chemical species. Thus, they can easily partake in substitution reactions with aromatic 
compounds and in addition reaction with alkenes, which is typical for aldehydes. An example of this high 
reactivity is the formation of molecular adducts with DNA, which may be a critical initiating event in the 
multistage process of chemical carcinogenesis (Yokoyama and Omori, 2003). Evidence of this type of 
reactivity is observed in reactions between formaldehyde, which has the simplest structure among 
aldehydes, and DNA. This reaction forms malondialdehyde-deoxyguanosine adducts, which are found in 
pathologists who are occupationally exposed to formaldehyde (Bono et al. , 2010). Moreover, AA has been 
demonstrated to form adducts in reactions involving a number of proteins, such as albumin (Donohue et al. 
, 1983) and haemoglobin (Stevens et al. , 1981), and also with DNA: the resulting DNA adduct in humans is a 
Schiff base N2-ethylidene-2’-deoxyguanosine (N2-ethylidene-dG) adduct (Vaca et al. , 1995). 
Concerning the development of alcoholic liver disease, multiple factors have been suggested. There has 
been increased interest in focusing on the possible role of immune mechanisms in the pathogenesis and 
perpetuation of this type of disease. In fact, many features of alcoholic liver disease suggest that immune 
mechanisms may contribute to liver tissue damage, as evidenced by the detection of circulating auto-
antibodies and the presence of CD4+ and CD8+ lymphoid cells in the livers of diseased patients (Cook et al. , 
1996; Szabo, 1998). In particular, AA derived from the metabolism of ethanol has been shown to form 
stable adducts with plasma-circulating proteins, such as albumin, which are recognised by the immune 
system as foreign in both animals and in humans. Indeed, studies by Israel et al. have shown a type I 
hypersensitivity reaction yielding IgE antibodies against AA adducts when mice were immunised with 
plasma proteins binded with AA (Israel et al. , 1992). Human studies showed an increase in anti-AA-albumin 
IgE antibodies among individuals who consume alcoholic beverages (Israel et al. , 1992). 
Humans naturally exhibit basal antibody titres against AA-protein adducts, which is likely due to variation in 
the amount of alcohol that is typically consumed throughout an individual’s lifetime. Some alcoholics 
present significantly higher levels of anti-AA proteins and adduct antibodies (Hoerner et al. , 1986; Niemela 
et al. , 1987; Worrall et al. , 1989), which have been proposed as factors that perpetuate alcohol-induced 
liver injury (Niemela et al. , 1987). Other findings also show the existence in alcoholics of antibodies that 
specifically react with hepatocytes of animals pre-treated with alcohol (MacSween et al. , 1981; Neuberger 
et al. , 1984), thus highlighting a cytotoxic and auto-immune effect due to the existence of AA-protein 
adducts. 
By chemical analogy, Thrasher et al. (Thrasher et al. , 1988; Thrasher et al. , 1987) demonstrated that 
formaldehyde binds Human Serum Albumin (HSA) covalently, giving rise to a molecular adduct  having 
formaldehyde as hapten. They found antibodies to the formaldehyde-HSA adduct in symptomatic subjects 
with long-term inhalation exposure to formaldehyde (Thrasher et al. , 1990). Haemoglobin (Hb) and HSA 
are preferred for monitoring molecules because they are accessible in large amounts, are chemically stable 
and are not prone to repair mechanisms such as DNA-adducts. Because of the long life span of Hb 
(approximately 120 days) and the long half-life of HSA (approximately 19 days (Kratz, 2008)), these adducts 
accumulate in the human body, making their concentrations very sensitive parameters for human 
biomonitoring (Angerer et al. , 2007). Similar results were found among smoker subjects who inhaled 
formaldehyde through smoke. In that analysis, the Displacement Assay was confirmed to be a useful 
method for evaluating formaldehyde exposure (Carraro et al. , 1997). 
There were two primary aims of this work. First, the correlation between AA-HSA antibodies (AA-HSA ab) 
and the amount of alcohol intake was investigated. Second, to investigate a possible role for the AA-HSA 
adduct as an early indicator of the biological effect of alcohol intake, it was necessary to quantify the 
immune activity of this adduct in typical alcohol consumers. 
 2. MATERIALS AND METHODS 
2.1 Epidemiological sampling and questionnaire 
The sample population was chosen among blood donors of A.V.I.S. Association (Associazione Volontari 
Italiani Sangue - Torino), without any a priori selection concerning drinking habits. Subjects were informed 
about the objective of the study, and after asking for their voluntary participation, a written consent form 
was signed and collected. Through this procedure, 76 healthy subjects overall were recruited during a 
sampling period of four months.  
A questionnaire was administered to all 76 of the subjects, who were all healthy and regular alcohol 
consumers or teetotalers, without any subjects alcohol-addicted. Information about individual and clinical 
features, smoking habits, and profession were acquired through specific questions about type, quantity and 
frequency of alcoholic drinks were asked. 
The quantity of ethanol assumed varies among different type of alcoholic beverages; specifically, ethanol 
intake was calculated taking into account its specific weight (= 0.8 gr/cm3), the percentage in volume (% 
vvol.) of ethanol quantity of beverages, and the volume ingested. Thus, a number of grams of ethanol was 
attributed to each subject, taking into account the self-reported average daily alcohol consumption in the 
questionnaire and the values suggested by the literature reported in Table 1. 
 
Table 1: Grams of ethanol in different types and volumes of beverages (Taggi, 2007). 
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BEER 
0,05 %vvol. 0.1 0.1 0.1 0.1 - - 
0.5% vvol. 1 1 1 1 - - 
2,5 % vvol. 7 5 4 3 2 1 
5% vvol. 13 10 8 6 4 1 
8 % vvol. 21 16 13 10 6 2 
WINE 
10 % vvol. 27 20 16 12 8 3 
11,5%  vvol. 31 23 18 14 9 3 
12 % vvol. 32 24 19 14 10 3 
13 % vvol. 35 26 21 16 10 3 
LIQUEURS AND SPIRITS 
Aperitif 18% vvol. 48 36 29 22 14 5 
Bitter 27% vvol. 72 54 43 32 22 7 
Liqueur 33% vvol. 88 66 53 40 26 8 
Strong drink 43% vvol. 115 86 69 52 34 11 
Herb infuse 70% vvol. 187 140 112 84 56 18 
 
 
2.2 Blood sampling and displacement assay  
Taking into account possible cumulative effects of the target molecule, subjects had not undergone to any 
restriction concerning the drinking habits before the biological sampling day. 
After completing the questionnaire, a whole blood sample (10 mL) was collected from each subject to 
perform the IgG anti-AA-HSA analysis, with the Displacement Assay, considering the analogous reactivity 
among aldehydes. The Displacement Assay was the analytical method chosen for anti-AA-HSA ab 
quantification, as it assured high sensitivity for the seroprevalence screening of FA-HSA IgG in an healthy 
population study (Carraro et al. , 1999; Carraro et al. , 1997); through this method an indirect measurement 
of AA-HSA adduct can be provided. This assay was applied as described by Gilli et al. (Gilli et al. , 2008), with 
no other relevant modifications. This test is based on a competitive reaction of human IgG antibodies 
against AA-HSA with rabbit IgG anti-AA-HSA antibodies. Briefly, human serum (1:8 titer, 200 µL)  (Thrasher 
et al. , 1990)  obtained from heparinized blood was incubated with the antigens (2 h at 37 ◦C), and then 
purified rabbit IgG (1:1000 titer, 200 µl) were added (2 h incubation at 37 ◦C). The reliability of the 
immunological response to AA-HSA was evaluated by comparison with the response against HSA. Positive 
responses in the human sera were revealed by a decrease of the optical density (OD) compared with the 
OD value obtained with rabbit IgG (positive control). The subject response was considered positive 
(presence of AA-HSA adduct antibodies) when the sample OD was lower than the positive control OD 
(rabbit serum). Negative responses (absence of antibodies to AA-HSA) resulted when the sample OD was 
greater or equal to that of the positive control. AA exposure marker value was calculated as the difference 
between the OD of the positive control and the OD of the serum sample: marker of AA exposure = (OD 
positive control) − (OD sample). The degree of displacement was revealed using a specific swine anti-rabbit 
antiserum (1:2500 titre, 200 µl) not showing cross-reactivity with human IgG. Optical densities were read at 
492 nm with a micro-plate reader (Tecan Infinite M200 Pro, Tecan Trading AG, Switzerland) after addition 
of the substrate 1,2-o-phenylendiamine dihydrochloride. 
 
 
2.3 Statistical analysis 
Student's t-test and one-way analysis of variance (ANOVA) were applied to compare two or more groups of 
independent samples, respectively, while Pearson’s correlation was used to test for possible associations 
between the variables. In particular, for ANOVA testing, the homogeneity of the variance was firstly 
assessed through the Levene test, thus the equal variance of Tukey’s test was assumed for post-hoc 
multiple comparisons.  
Finally, a P value of ≤ 0.05 (two-tailed) was considered to be significant for all tests. All of the statistical 
analyses were performed using SPSS Package, version 17.0. 
 
 
3. RESULTS 
Age and gender were controlled  in the sample population (N=76), as males (N=41) were not significantly 
older than females (N=35) (44.1 ± 13.7 vs. 39.1 ± 12.8; p = 0.101). As tobacco smoke could be considered 
one of the sources of AA, smoking habits were considered to be possible confounding factors in the 
subsequent measurements. Smokers comprised 23.7% of the sample population, and there was no 
appreciable difference in the representation of smokers among males (22%) and females (25.7%) (p = 
0.706). Additionally, the number of cigarettes smoked per day was similar among male and female smokers 
(males: 3.1 cigarettes/day ± 7.4 vs. females: 2.9 cigarettes/day ± 6.2; p = 0.878).  
Regarding alcohol consumption, subjects were divided into 3 groups: “nondrinkers” if they had never 
consumed an alcoholic drink (e.g. teetotallers), “slight drinkers” if they occasionally consumed alcoholic 
drinks (e.g. if they declared that they rarely consumed alcohol, or if they were former drinkers), and finally 
“regular drinkers” (e.g. if they drink during meals). These groups were used to analyse the correlation 
between grams of ethanol consumed and the amount of circulating AA-HSA ab. The “nondrinkers” 
appeared to be the less numerous group, with 16 subjects representing 21.1% of the sample population. By 
contrast, “regular drinkers” represented 43.4% of the sample population with 33 subjects. Finally, 27 
subjects (35.5%) belonged to the “slight drinkers” group. The majority of “nondrinkers” and “slight drinkers” 
were females, with females in these groups representing 40% and 42.9% of all females in the sample 
population, respectively.  Conversely, males comprised the majority of “regular drinkers” with 65.9% of all 
males in the sample population.  
Table 2 shows the grams of ethanol daily average intake inferred by the questionnaire and mean values of 
the AA-HSA ab marker stratified by gender and drinking habits. Alcohol intake in males was statistically 
higher than in females (males 19.1 ± 13.6 vs. female 4.2 ± 5.4; P ≤ 0.0001); however, no statistically 
significant differences for alcohol intake were found between males and females within population sub-
groups defined by drinking habits. 
Concerning the AA-HSA adducts, an interesting statistically significant difference was observed for AA-HSA 
Ab presence by gender (males 0.07 ± 0.02 vs. females 0.05 ± 0.03; P = 0.03), but this difference in the 
distribution was absent in subgroups stratified by drinking habits.  
 
 
 
Table 2: Classification of subjects recruited in the seroepidemiological study according to gender, ethanol 
intake, smoking habits and AA-HSA ab levels. 
 
 Population study 
(N=76) 
Male 
(N=41) 
Female 
(N=35) 
Ethanol (g.)    mean ± SD 12.2 ± 13 19.1 ± 13.6 4.2 ± 5.4 
Nondrinkers N; mean ± SD 16; 0 2; 0 14; 0 
Slightly drinkers N; mean ± SD 27; 5.4 ± 4.1 12; 6.9 ± 5.6 15; 4.2 ± 1.8 
Regular drinkers N; mean ± SD 33; 23.7 ± 11.4 27; 25.9 ± 11.3 6; 13.8 ± 5.3 
Anti-AA-HSA-ab     mean ± SD 0.06 ±0.02 0.07 ± 0.02 0.05 ± 0.03 
aNot smokers nondrinkers (N=12) vs smokers regular drinkers (N=7) (P <0.0001) 
bNot smokers nondrinkers (N=12) vs not smokers regular drinkers (N=26) (P= 0.01) 
cNot smokers slightly drinkers (N=20) vs smokers regular drinkers (N=7) (P = 0.05) 
dSmokers nondrinkers (N=4) vs smokers regular drinkers (N=7) (P = 0.005) 
eSmokers slightly drinkers (N=7) vs smokers regular drinkers (N=7) (P = 0.03) 
 
 
Mean values of this biological marker were also compared among the sample population stratified by 
tobacco smoke, but no statistical difference was found  between smokers and not smokers (N = 18; 0.06 ± 
0.04 and N = 58; 0.06 ± 0.02 respectively). However, to better investigate the sensitivity of this biological 
marker, molecular AA-HSA ab levels were compared among the entire population by taking into account 
both smoking habits and daily alcohol consumption. Thus, six sub-groups were generated, as shown in  
Table 2, where a globally significant model of data distribution is given (P ≤ 0.0001).  
From this approach, AA-HSA ab mean values show a similar trend when comparing smokers and non-
smokers with increased alcohol intakes. In particular, significant comparisons between each of the six 
resulting groups were detailed in Table 2 and confirmed by performing Tukey’s test post hoc. This 
approach, however, resulted in relatively small sample sizes among groups, especially when the subgroups 
were furtherly compared by gender (not statistically significant comparisons). 
Finally, from the correlation analysis, a significant relationship between values of ethanol daily intake and 
AA-HSA ab was observed (Pearson’s r = 0.462; P ≤ 0.0001) (Fig.1), conversely, a not significant relation 
between AA-HSA ab and smoking habits (measured by n° of cigarettes/day) among smokers was reported 
(N=18; Pearson’s r = 0,064; p = 0,801; data not shown). 
 
 
Not smokers  
(N = 58) 
1- Nondrinkers N; mean ± SD 12; 0.04 ± 0.01a, b 2; 0.05 ± 0.002 10; 0.04 ± 0.01 
2- Slightly drinkers N; mean ± SD 20; 0.06 ± 0.02c 7; 0.07 ± 0.02 13; 0.05 ± 0.01 
3- Regular drinkers N; mean ± SD 26; 0.06 ± 0.02 23; 0.07 ± 0.02 3; 0.05 ± 0.02 
Smokers  
(N = 18) 
4- Nondrinkers N; mean ± SD 4; 0.04 ± 0.05d 0 4; 0.04 ± 0.05 
5- Slightly drinkers N; mean ± SD 7; 0.05 ± 0.02e 5; 0.05 ± 0.02 2; 0.04 ± 0.002 
6- Regular drinkers N; mean ± SD 7; 0.09 ± 0.02 4; 0.08 ± 0.02 3; 0.1 ± 0.03 
4. DISCUSSION 
The first aim of this study was to measure AA-HSA adducts values, a molecular marker linked to AA, which 
exposure is associated with alcohol consumption and airborne pollution. This result is unexpected, as it is 
already evident among subjects who are in the normal range of drinking habits. Indeed, most studies 
concerning this topic are focused on stronger drinking habits, often including alcohol abuse, where 
correlations between the exposure to ethanol and levels of the AA-HSA biological marker are stricter 
(Neuberger et al. , 1984; Worrall et al. , 1989). With these prior observations, it is important to investigate 
what values of AA-HSA ab can be expected in a healthy population with a normal range of ethanol intake. 
This investigation can help determine new conditions for defining very earlier stages of health effects 
alcohol-related.  
Other kind of assay have been considered as top test for the evaluation of drinking status, in particular the 
CDT quantification (= Carbon Deficient Transferrin) is widely diffuse; however the accuracy for this marker 
is generally poorer among drinkers with a low level of alcohol consumption, younger and women 
(Gronbaek et al. , 1995), conversely it seems to be suitable in distinguish chronic and heavy drinkers 
subjects (Sillanaukee et al. , 2001).   
Also Ethyl Glucuronide quantification in hair (HEtG) has recently gained great attention, because of the high 
sensitivity and specificity in the diagnosis of chronic heavy drinking (Hoiseth et al. , 2009; Morini et al. , 
2009; Morini et al. , 2010), and it has been recently adopted by the Society of Hair Testing for the chronic 
excessive alcohol consumption assessment (Soht, 2009). In general the quantification of a marker 
measured in hair provide an indication about possible cumulative and time-dependent effects of the 
substance, since the hair growth is estimated about 1 cm/month; on the other hand this concern affects 
the sensitivity of the technique, especially when subjects are in the regular range of alcohol use. 
Conversely, HSA exhibits a shorter average life-time (Kratz, 2008) and represents the main target of AA, on 
which an immune reaction takes place; in our view such type of reaction is better defined through a 
biological and dynamic assay, especially when low levels of ethanol could be expected as in the general 
healthy population. 
It’s also important to note that certain common non-alcoholic beverages, including sodas and fruit juices, 
contain small amount of ethanol (Logan and Distefano, 1998) in which it is present as result from 
fermentation processes of sugar or sugarcane, as well as baked foods, in which ethanol is used as 
antimicrobial agent. All these foods are widely consumed, thus this could explain the amount of AA-HSA ab 
among non and slightly drinkers subjects. 
Further AA exposure was also investigated, taking into account exposure to tobacco smoke as possible 
source of air pollution. Far from our hypothesised results and expectations based on the literature, AA-HSA 
adduct levels do not show any appreciable differences between populations stratified by tobacco smoke 
exposure. In fact, this study indicates that AA-HSA ab formation does not seem to depend on tobacco 
smoke intake. Moreover, these findings were reinforced by the results shown in Table 2, in which both 
smoking habits and alcohol intake were considered together as potential contributors in AA-HSA ab 
induction. Although non-smokers/nondrinkers have AA-HSA ab levels that are significantly lower than those 
of smokers/regular drinkers (p ≤ 0.0001), globally not-smokers have AA-HSA ab levels comparable to those 
of smokers. We suppose that this distribution could be due to differing sample sizes when comparing 
across smokers and not smokers (N= 18 vs. N=58, respectively) and to the low number of cigarettes smoked 
per day by smokers. Thus, the results shown in Table 2 seem to be better explained by differing levels of 
alcohol intake, where similar trends were observed within each drink category, rather than by smoking 
habits.  
Gender seems to be involved in the formation of AA-HSA ab, as values for the molecular adduct are 
significantly different between males and females. This result is most likely due to the little number of 
drinkers among females than those among males (females N=6 vs. males N= 27); on the other hand also 
differences in alcohol metabolism genetically pre-determined should be taken into account, even if 
literature provide quite controversial findings concerning gender and alcohol metabolism (Ramchandani et 
al. , 2001). However, when considering the sample population stratified by different alcohol consumption 
and smoking habits, differences between gender are missing. 
In conclusion, even considering the limited number of subjects analysed in this seroprevalence 
investigation, the results show that ethanol intake causes a clear antibody response, as highlighted by the 
formation of AA-HSA ab. The biological importance of these findings is linked to the possibility for useful 
applications of this molecular adduct as a biologically effective dose marker for ethanol exposure. Indeed, 
the need to promote healthy lifestyles among human populations, especially among younger 
demographics, arises from an awareness of alcohol abuse, smoking, and the consumption of drugs and 
unhealthy food as risk factors for poor health in the general population, as they can cause illness and 
mortality. The abuse of such substances causes high health care costs; consequently, their effects have a 
variety of consequences in healthcare administration, social contexts, and the workplace.  
For the above-mentioned reasons, the evaluation of the presence of AA-HSA ab can represent a useful 
approach for screening activities related to preventive actions.  
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FIGURE CAPTIONS 
 
 Figure 1: Bivariate correlation between quantity of assumed ethanol (g.) and AA-HSA ab values 
(OD). 
 
 
